Indication
Female Sexual Arousal Disorder
2 clinical trials
3 products
Clinical trial
Phase 2 Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women With Sexual Arousal DisorderStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
BZ371AProduct
PlaceboClinical trial
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in WomenStatus: Completed, Estimated PCD: 2023-04-15
Product
Caffeine